A Randomized, Placebo-Controlled Trial of Human Umbilical Cord Blood Mesenchymal Stem Cell Infusion for Children With Cerebral Palsy
Cerebral palsy (CP) is a common disability which results in permanent chronic motor disability appearing in early childhood. Recently human umbilical cord blood mesenchymal stem cell (hUCB-MSC) infusion has emerged as a promising therapeutic strategy for CP, and the treatment efficacy remains to be...
Main Authors: | Li Huang, Che Zhang, Jiaowei Gu, Wei Wu, Zhujun Shen, Xihui Zhou, Haixia Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-02-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/0963689717729379 |
Similar Items
-
Therapy for Cerebral Palsy by Human Umbilical Cord Blood Mesenchymal Stem Cells Transplantation Combined With Basic Rehabilitation Treatment
by: Che Zhang MD, et al.
Published: (2015-03-01) -
Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial
by: Jiaowei Gu, et al.
Published: (2020-02-01) -
Sibling umbilical cord blood infusion is safe in young children with cerebral palsy
by: Jessica M. Sun, et al.
Published: (2021-09-01) -
Umbilical Cord Blood and Umbilical Cord Tissue Mesenchymal Stromal Cells in Children with Cerebral Palsy: A Randomized Trial
by: Jessica Sun, et al.
Published: (2021-09-01) -
Prevention and treatment of cerebral palsy with cord blood stem cells and cord-derived mesenchymal stem cells
by: Haruo Shintaku
Published: (2021-01-01)